Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Prog Urol ; 31(8-9): 495-502, 2021.
Article in French | MEDLINE | ID: covidwho-1213486

ABSTRACT

OBJECTIVE: To assist urologists in the management of andrological and sexual medicine pathologies during the COVID-19 crisis. MATERIAL AND METHOD: Use of the formalized consensus method. RESULTS: The medical and surgical management of patients in andrology and sexual medicine must be adapted. Consultations should, as far as possible, be carried out by tele-consultation. For operative procedures, the delay between the operative decision and the date of (re)scheduling of the procedure will depend on: (1) the level of criticality of the clinical situation; (2) the type of intervention; (3) the functional and psychological repercussions, including quality of life while waiting for the procedure; (4) the notion of losing the chance of having an optimal outcome; (5) the risk of potential complications from delaying a procedure for too long; and (6) taking into account the patient's risk factors for severe forms of COVID-19. The protection of urologists from COVID-19 should be considered. Each urologist must make the best decision for the patient, taking into account the acceptable time frame and quality of life impact before surgical management, the COVID risk parameters, the technical and anesthetic feasibility and the structural possibility of the health care institution to ensure a specific dedicated pathway during the COVID-19 health crisis. CONCLUSION: The management of andrological and sexual medicine pathologies must be adapted to the COVID-19 crisis context. Some patients may require surgery, including in emergency. These recommendations are transitional and will end with the COVID-19 crisis.


Subject(s)
Penile Induration/diagnosis , Penile Induration/therapy , COVID-19 , Collagenases/therapeutic use , Combined Modality Therapy , Erectile Dysfunction/drug therapy , Humans , Injections , Male , Pandemics , Penile Implantation , Phosphodiesterase 5 Inhibitors/therapeutic use , Traction , Urologic Surgical Procedures, Male , Vacuum , Vasodilator Agents/therapeutic use , Verapamil/therapeutic use
2.
Prog Urol ; 30(5): 221-231, 2020 Apr.
Article in French | MEDLINE | ID: covidwho-25921

ABSTRACT

AIM: The French population is facing the COVID-19 pandemic and the health system have been reoriented in emergency for the care of patients with coronavirus. The management of cancers of the urinary and male genital tracts must be adapted to this context. MATERIAL AND METHOD: An expert opinion documented by a literature review was formulated by the Cancerology Committee of the French Association of Urology (CCAFU). RESULTS: The medical and surgical management of patients with any cancers of the urinary and male genital tracts must be adapted by modifying the consultation methods, by prioritizing interventions according to the intrinsic prognosis of cancers, taking into account the patient's comorbidities. The protection of urologists from COVID-19 must be considered. CONCLUSION: The CCAFU issues an expert opinion on the measure to be taken to adapt the management of cancers of the male urinary and genital tract to the context of pandemic by COVID-19.


Subject(s)
Coronavirus Infections , Disease Management , Infection Control , Pandemics , Pneumonia, Viral , Urogenital Neoplasms/surgery , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Decision Making , Epidemics , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Male , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Societies, Medical , Urologists
SELECTION OF CITATIONS
SEARCH DETAIL